Cargando…
STC2 activates PRMT5 to induce radioresistance through DNA damage repair and ferroptosis pathways in esophageal squamous cell carcinoma
Radioresistance is the major reason for the failure of radiotherapy in esophageal squamous cell carcinoma (ESCC). Previous evidence indicated that stanniocalcin 2 (STC2) participates in various biological processes of malignant tumors. However, researches on its effect on radioresistance in cancers...
Autores principales: | Jiang, Kan, Yin, Xin, Zhang, Qingyi, Yin, Jie, Tang, Qiuying, Xu, Mengyou, Wu, Lingyun, Shen, Yifan, Zhou, Ziyang, Yu, Hao, Yan, Senxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929488/ https://www.ncbi.nlm.nih.gov/pubmed/36764215 http://dx.doi.org/10.1016/j.redox.2023.102626 |
Ejemplares similares
-
Ciclopirox Olamine Exerts Tumor-Suppressor Effects via Topoisomerase II Alpha in Lung Adenocarcinoma
por: Yin, Jie, et al.
Publicado: (2022) -
Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer
por: Jiang, Kan, et al.
Publicado: (2022) -
CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription
por: Huang, Sheng, et al.
Publicado: (2018) -
CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair
por: Zhou, Yuzhen, et al.
Publicado: (2018) -
Downregulation of H19 decreases the radioresistance in esophageal squamous cell carcinoma cells
por: Luo, Wenguang, et al.
Publicado: (2019)